What is changing in the rules, what it means for your product, your municipality or your project, and who here handles it. In English and Portuguese.
Our monitoring reports record the changes to cosmetics rules in a given period, and we publish one each month. Each one is a dated publication: it reflects the rules on the date it was published and is not updated afterwards. For what applies today, read the latest briefings or ask us.
Ingredients: HEXYLSALICYLATE
Date of publication: 28/02/2024
On February 28 2024, the Scientific Committee on Consumer Safety (SCCS) published the Final Opinion on the use of fragrance Hexyl Salicylate in cosmetic products.
Topic: Draft 22nd ATP to CLP Regulation
Date of publication: 18/01/2024
On January 18, 2024, the European Commission (EC) notified the World Trade Organization's (WTO) Technical Barriers to Trade (TBT) Committee about the 22nd Adaptation to Technical and Scientific Progress (ATP) to Regulation (EC) 1272/2008, also known as CLP Regulation. This update amends 42 substances or substance groups and deletes one entry.
Date of publication: 01/02/2024
List of updates that come into force in 2024.
Date of publication: 01/02/2024
From January 1, 2025, market of personal care products containing fluorinated greenhouse gases shall be prohibited. </b
Topic: REQUIREMENTS FOR COSMETICS SOLD ONLINE – GPSR – REGULATION 2023/988
Date of publication: 23/05/2023
Article 19 of the GPSR Regulation 2023/988 stipulates the requirements that must be fulfilled by the economic operators to be able to sell cosmetics online.
Ingredients: METHYLPARABEN
Date of publication: 14/12/2023
On December 14 2023, the Scientific Committee on Consumer Safety (SCCS) published the Final Opinion on Methylparaben.
Ingredients: ALUMINIUM
Date of publication: 14/12/2023
On December 14 2023, the Scientific Committee on Consumer Safety (SCCS) published the Preliminay Opinion on the use of aluminium in cosmetic products. The deadline for comments is set to February 16, 2024.
Ingredients: BENZOPHENONE-4
Date of publication: 14/12/2023
On December 14 2023, the Scientific Committee on Consumer Safety (SCCS) published the Preliminary Opinion on the use of Benzophenone-4 in cosmetic products. The deadline for comments is set to February 16, 2024.
Ingredients: ALUMINIUM
Date of publication: 14/12/2023
On December 14 2023, the Scientific Committee on Consumer Safety (SCCS) published the Preliminay Opinion on the use of aluminium in cosmetic products. The deadline for comments is set to February 16, 2024.
Ingredients: MICROPLASTICS
Date of publication: 27/09/2023
On 27 September, 2023, the European Commission published Regulation (EU) 2023/2055 which introduces stricter restrictions on products that contain intentionally-added microplastics, including cosmetics.
Ingredient: CYCLAMEN ALDEHYDE
Date of publication: 8 June 2026
The Scientific Committee on Consumer Safety (SCCS) has accepted a mandate to assess the safety of Cyclamen Aldehyde, following potential classification as a reproductive toxicant under the CLP Regulation.
Topic: OMNIBUS ACT IX - COSMETICS REGULATION
Date of publication: 28 July 2026
The European Commission notified the WTO about the draft Omnibus Act IX, proposing amendments to Annexes II, III, and V of the EU Cosmetics Regulation.
Topic: NEW RESTRICTIONS ON COSMETIC INGREDIENTS
Date of publication: 13 January 2026
The European Commission published Commission Regulation (EU) 2026/78, which brings new restrictions on several cosmetic ingredients that were classified as Carcinogenic, Mutagenic or Toxic for Reproduction (CMR).
Ingredient: TALC
Date of publication: January 2026
The United Kingdom (UK) Health and Safety Executive (HSE) has published a technical report concluding that Talc does not warrant carcinogenicity classification, diverging from ECHA's Risk Assessment Committee (RAC) opinion supporting Category 1B classification.
Four EUDAMED modules have been mandatory since 28 May 2026. Devices already on the market have until 27 November 2026. Who registers what, and what changed in Portugal.
From 25 February 2027, notified bodies under the MDR and IVDR must quote on defined information, keep to maximum timelines and publish their performance. What it changes for manufacturers.
Whether software is a medical device depends on what you say it is for, not on the code. The qualification test under the MDR and IVDR, updated for 2025 guidance.
Clinical data from an equivalent device can support your clinical evaluation, but the MDR sets a higher bar than the Directives did. The three characteristics, data access, and documentation.
One email when an area publishes, in the language you choose. Nothing else.
